Cinctive Capital Management LP Penumbra Inc Transaction History

Cinctive Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $686,240 - $851,681	3,118 New	3,118 $695,000
Q1 2022 May 16, 2022	SELL	$187.51 - $283.98 $5.46 Million - $8.26 Million	-29,092 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$238.08 - $288.0 $2.65 Million - $3.2 Million	11,126 Added 61.93%	29,092 $8.36 Million
Q3 2021 Nov 15, 2021	BUY	$250.72 - $291.24 $674,687 - $783,726	2,691 Added 17.62%	17,966 $4.79 Million
Q2 2021 Aug 16, 2021	BUY	$235.0 - $310.7 $2.98 Million - $3.94 Million	12,669 Added 486.15%	15,275 $4.19 Million
Q1 2021 May 17, 2021	BUY	$175.6 - $291.43 $457,613 - $759,466	2,606 New	2,606 $705,000

399

29.2M

312K

187K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $10.3B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.